1197584

AstraZeneca Pharmaceuticals LP — FEI 3002617771

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 19, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Frederick, MD (United States)